Cell and gene therapies: Pipe dream to pipeline The cell and gene industry is gaining momentum, with a new wave of therapies promising to transform the way doctors treat, and even cure, disease. In this report, Cytiva and GlobalData have collaborated to explore the rise of the cell and ...
Science Areas of Focus Revolutionary medicines enable us to enrich and extend life for people living with all types of diseases. Rare Disease Internal Medicine Inflammation & Immunology Vaccines Oncology Anti Infectives Pipeline Snapshot as of April 29, 2025 ...
Pfizer is currently focusing on diseases that have single-gene defects, such as certain neuromuscular and hematologic diseases, and we have a robust pipeline of potential gene therapy treatments in preclinical and clinical development. Our current portfolio includes a phase 1b clinical trial for ...
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!
Gerberry also notes that a Pfizer gene therapy candidate — PF-06939926 for Duchenne muscular dystrophy — is closer to the endzone than many current and would-be owners of PFE stock may realize. Though in Phase 1 testing right now, should the R&D update slated for the middle of the year...
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development! Find out more Latest News View All News Email Alerts To...
“Biologics continue to be an integral part of Pfizer’s pipeline, and this acquisition will expand our research, clinical, and commercial manufacturing capacity and help us accelerate the development of our pipeline products as well as support our Pfizer CentreOne customers,” said Mike Mc...
Pfizer will go toe-to-toe with CSL Behring following the FDA’s Friday approval of its hemophilia B gene therapy Beqvez and will launch a warranty program based on the durability of response.
breakthroughs that dramatically improve the lives of people with cancer. Of course, we are also working to develop future breakthroughs where we have the opportunities to bring the most important new therapies to patients in need. I will review several recent pipeline highlights, starting with ...
breakthroughs that dramatically improve the lives of people with cancer. Of course, we are also working to develop future breakthroughs where we have the opportunities to bring the most important new therapies to patients in need. I will review several recent pipeline highlights, starting with ...